The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer.

Although adult and pediatric papillary thyroid cancer (PTC) share similar oncogenic drivers, they differ in the pathological features and outcomes of the disease. In adults with PTC, the most frequent genetic alterations are mutually exclusive point mutations in BRAFV600E or the RAS family with BRAFV600E commonly associated with invasive disease and decreased response to radioiodine therapy. In pediatric PTC, fusion oncogenes involving chromosomal translocations in tyrosine kinase (TK) receptors, most commonly RET and NTRK, are often found in patients with lateral neck and distant metastases. This brief report reviews clinical data from a single-institute's cohort of NTRK-driven pediatric PTC cases with an updated review of the literature and comparison to adult NTRK-driven PTC. Copyright © 2022 Elsevier Inc. All rights reserved.

Citation

Julio C Ricarte-Filho, Stephen Halada, Alison O'Neill, Victoria Casado-Medrano, Theodore W Laetsch, Aime T Franco, Andrew J Bauer. The clinical aspect of NTRK-fusions in pediatric papillary thyroid cancer. Cancer genetics. 2022 Apr;262-263:57-63

Mesh Tags

Substances

PMID: 35092884

search → result